Maggie C. (Eidson) Fader MD

Pediatric Hematology & Oncology•Miami, FL

Pediatric Hematologic Oncology, Pediatric Sarcoma Oncology, Pediatric Solid Tumor Oncology

Director, Pediatric Sarcoma and Solid Tumor Program

Join to View Full Profile

3100 SW 62 Avenue -NE Wing #121#121Miami, FL 33155
Phone+1 305-662-8360
Fax+1 305-666-6387

Summary

Dr. Maggie Fader is a pediatric hematologist/oncologist in Miami, FL, affiliated with Nicklaus Children's Hospital. She completed her fellowship at Weill Cornell Medical/Memorial Sloan Kettering Cancer Center and has been practicing 15 years. She speaks English and Spanish. She treats osteosarcoma, ewing sarcoma, neuroblastoma, rhabdomyosarcoma, leukemia, lymphoma and pediatric solid tumors.

Education & Training

New York Presbyterian Hospital (Cornell Campus)Fellowship, Pediatric Hematology/Oncology, 2006 - 2009
University of Miami/Jackson Health SystemResidency, Pediatrics, 2002 - 2005
University of Miami Leonard M. Miller School of MedicineClass of 2002

Certifications & Licensure

FL State Medical License 2005 - 2026
NY State Medical License 2005 - 2011
American Board of Pediatrics Pediatrics
American Board of Pediatrics Pediatric Hematology-Oncology

Awards, Honors, & Recognition

PETALS Recogntion Program Honoree Nicklaus Children’s Hospital, 2024

Clinical Trials

Studying the Effect of Levocarnitine in Protecting the Liver From Chemotherapy for Leukemia or Lymphoma Start of enrollment: 2023 Aug 24
RECRUITING
PHASE3
Thoracotomy Versus Thoracoscopic Management of Pulmonary Metastases in Patients With Osteosarcoma Start of enrollment: 2022 Apr 01
RECRUITING
PHASE3
A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs, Brentuximab Vedotin and Nivolumab Start of enrollment: 2023 May 11
RECRUITING
PHASE3
Active Surveillance, Bleomycin, Etoposide, Carboplatin or Cisplatin in Treating Pediatric and Adult Patients With Germ Cell Tumors Start of enrollment: 2017 May 25
RECRUITING
PHASE3
Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma Start of enrollment: 2024 Apr 19
RECRUITING
PHASE3
Ex Vivo Drug Sensitivity Testing and Multi-Omics Profiling Start of enrollment: 2023 Feb 22
Recruiting
Enasidenib for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia Patients With an IDH2 Mutation Start of enrollment: 2023 Aug 14
RECRUITING
PHASE2
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study Start of enrollment: 2022 Apr 18
RECRUITING
PHASE1, PHASE2
A Study of Combination Chemotherapy for Patients With Newly Diagnosed DAWT and Relapsed FHWT Start of enrollment: 2020 Oct 19
RECRUITING
PHASE2
Chemotherapy for the Treatment of Patients With Newly Diagnosed Very Low-Risk and Low Risk Fusion Negative Rhabdomyosarcoma Start of enrollment: 2022 Aug 04
RECRUITING
PHASE3
Join now to see all

Publications & Presentations

PubMed

Malignant Ectomesenchymoma in a 6-Month-Old: A Rare Pediatric Tumor Case Report.
Juanita Velasquez Ospina, Luciana Lerendegui, Paulo Moscardi, Daniel M Tennenbaum, Liset Pelaez
Urology. 2025-01-30
Variant Pseudocystic Desmoplastic Small Round Cell Tumor With Heterologous Mullerian Cysts.
Eric I Nayman, Carole Brathwaite, Felipe Pedroso, Maggie E Fader, Farres Obeidin
Pediatric and Developmental Pathology. 2025-01-09
An Oncoplastic Approach to Primary Pediatric Pterygomaxillary Osteosarcoma.
Ashley L Ramirez, Alexandra N Townsend, Lee Weber, Pedro S Piccinini, Erin M Wolfe
The Cleft Palate-Craniofacial Journal. 2024-06-01

Press Mentions

Miami-Based Oliver Patch Project Empowers Children Battling Cancer with Custom Denim Jackets and PatchesSeptember 24th, 2024
Nicklaus Children’s and FIU Collaborate on Groundbreaking Cancer Research That Is Saving LivesMay 19th, 2024
What Aidan Taught Me and John HopkinsJanuary 8th, 2018
Join now to see all